mRNA-4194 clinical trials

A clinical trial testing a new treatment called mRNA-4194 for people with Lynch syndrome

This study tests a new treatment, mRNA-4194, for people with Lynch syndrome. It aims to train the immune system to find and destroy early abnormal cells, potentially preventing cancer. Participants will receive injections and have regular health checks.